换一批
换一批Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit.
作者：
主题词
肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);苄胺类(Benzylamines);钙通道阻滞药(Calcium Channel Blockers);心肌病, 肥厚性(Cardiomyopathy, Hypertrophic);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);生活质量(Quality of Life);治疗结果(Treatment Outcome);美国(United States);尿嘧啶(Uracil)
DOI
10.1016/j.clinthera.2021.11.006
PMID
34911641
发布时间
2022-05-31
- 浏览2
Clinical therapeutics
52-66.e2页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
